Prevalence and individual factors associated with unsuppressed viral load among HIV patients receiving antiretroviral therapy at Ndejje Health Centre IV, Wakiso district.  A cross-sectional study.

Ali  Ssemanda; Richard Miiro; Hasifah Nansereko; Franscisco Ssemuwemba; Jane Frank  Nalubega; Immaculate Prosperia  Naggulu

doi:10.51168/sjhrafrica.v7i3.2410

Authors

Ali Ssemanda Mildmay Institute of Health Sciences.
Richard Miiro Mildmay Institute of Health Sciences.
Hasifah Nansereko Mildmay Institute of Health Sciences.
Franscisco Ssemuwemba Mildmay Institute of Health Sciences.
Jane Frank Nalubega Mildmay Institute of Health Sciences.
Immaculate Prosperia Naggulu Mildmay Institute of Health Sciences.

DOI:

https://doi.org/10.51168/sjhrafrica.v7i3.2410

Keywords:

HIV/AIDS, Unsuppressed viral load, Antiretroviral therapy (ART), Ndejje Health Centre IV, Wakiso District

Abstract

Background:
Unsuppressed HIV viral load remains a major public health challenge among people living with HIV receiving antiretroviral therapy (ART), particularly in low- and middle-income countries. This study assessed the prevalence and individual factors associated with unsuppressed viral load among HIV patients receiving ART at Ndejje Health Centre IV, Wakiso District.

Methodology:
A descriptive cross-sectional study was conducted among 77 HIV-positive adults aged 18 years and above who had been on ART for at least six months. Participants were selected using purposive sampling. Data were collected using semi-structured questionnaires and supplemented with clinical records for viral load results. Data were analyzed using descriptive statistics, including frequencies and percentages.

Results:
Most participants were aged 25–34 years (36.4%) and female (57.1%). The prevalence of unsuppressed viral load was 33.8% (26/77), while 66.2% (51/77) had suppressed viral loads. The majority had primary education (36.4%) and were unemployed (40.3%). Most respondents reported having family or social support for HIV treatment (66.2%), while 29.9% experienced stigma or discrimination. Individual factors, such as unemployment, lower educational level, and limited social support, were identified as potential contributors to unsuppressed viral load.

Conclusion:
The prevalence of unsuppressed viral load among patients receiving ART at Ndejje Health Centre IV was relatively high, indicating ongoing challenges in achieving optimal treatment outcomes. Socioeconomic factors, education level, and social support appear to influence viral suppression among patients on ART.

Recommendations:
Healthcare providers should strengthen adherence counseling, particularly for patients who are socioeconomically vulnerable. The Ministry of Health and partners should integrate economic empowerment programs and community support interventions to improve adherence and retention in care. Routine viral load monitoring and stigma reduction strategies should also be enhanced to improve treatment outcomes.

Author Biographies

Ali Ssemanda , Mildmay Institute of Health Sciences.

is a student of a diploma in Medical Laboratory Technology at Mildmay Institute of Health Sciences.

Richard Miiro, Mildmay Institute of Health Sciences.

is a research supervisor at Mildmay Institute of Health Sciences.

Hasifah Nansereko, Mildmay Institute of Health Sciences.

is a research supervisor at Mildmay Institute of Health Sciences.

Franscisco Ssemuwemba, Mildmay Institute of Health Sciences.

is a research supervisor at Mildmay Institute of Health Sciences.

Jane Frank Nalubega, Mildmay Institute of Health Sciences.

is a research supervisor at Mildmay Institute of Health Sciences.

References

Akugizibwe, P., Atuhaire, C., Kiconco, R., & Nuwagira, E. (2023). Retention in HIV care and associated factors among patients receiving antiretroviral therapy at Wakiso Health Centre IV, Uganda. BMC Health Services Research, 23(1), 1–10.

Fei, X., Zhang, Y., Li, H., & Chen, J. (2025). Viral load suppression and associated factors among people living with HIV on antiretroviral therapy in Asia: A multicountry analysis. The Lancet Regional Health – Western Pacific, 45, 100921.

Johnson, L. F., Dorrington, R. E., Moolla, H., & Scheibe, A. (2021). Progress towards the 95-95-95 targets in South Africa: Data trends and treatment outcomes. South African Medical Journal, 111(8), 737–744.

Magezi, V. (2022). Adherence challenges and treatment outcomes among children and adolescents receiving antiretroviral therapy at Ndejje Health Centre IV, Wakiso District. Unpublished report, Uganda Ministry of Health.

Tumusiime, D. K., Ssempijja, V., Nakanjako, D., & Kamya, M. R. (2025). Viral load suppression and treatment outcomes among people living with HIV in Uganda: National programmatic data analysis. AIDS Research and Therapy, 22(1), 15–24.

AYele, T. A., Tessema, G. A., & Kassa, A. M. (2018). Prevalence and associated factors of treatment failure among people living with HIV on antiretroviral therapy in Ethiopia: A systematic review and meta-analysis. BMC Infectious Diseases, 18(1), 1–12. https://doi.org/10.1186/s12879-018-3501-3

Bulage, L., Ssewanyana, I., Nankabirwa, V., Nsubuga, F., Kihembo, C., Pande, G., Ario, A. R., & Wabwire-Mangen, F. (2017). Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, 2014–2015. BMC Infectious Diseases, 17(1), 326. https://doi.org/10.1186/s12879-017-2428-3

Kipp, W., Konde-Lule, J., Saunders, L. D., Alibhai, A., Houston, S., Rubaale, T., & Okech-Ojony, J. (2010). Antiretroviral treatment for HIV in rural Uganda: Two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort. PLoS ONE, 5(7), e11594. https://doi.org/10.1371/journal.pone.0011594

Ministry of Health, Uganda. (2022). Consolidated guidelines for prevention and treatment of HIV and AIDS in Uganda. Kampala, Uganda: Ministry of Health.

Nasuuna, E., Kigozi, J., Babirye, L., Muganzi, A., Sewankambo, N., & Nakanjako, D. (2018). Low HIV viral suppression rates following the intensive adherence counseling program for HIV clients with viral failure in Uganda. BMC Public Health, 18(1), 1048. https://doi.org/10.1186/s12889-018-5964-9

Turan, B., Budhwani, H., Fazeli, P. L., Browning, W. R., Raper, J. L., Mugavero, M. J., & Turan, J. M. (2017). How does stigma affect people living with HIV? The mediating roles of internalized and anticipated HIV stigma in the effects of perceived community stigma on health and psychosocial outcomes. AIDS and Behavior, 21(1), 283–291. https://doi.org/10.1007/s10461-016-1451-5

UNAIDS. (2023). Global AIDS update 2023: The path that ends AIDS. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS). https://doi.org/10.18356/9789210028370

Wringe, A., Isingo, R., Urassa, M., Maiseli, G., Manyalla, R., Changalucha, J., Kalluvya, S., Zaba, B., & Todd, J. (2009). Uptake of HIV voluntary counselling and testing services in rural Tanzania: Implications for effective HIV prevention and equitable access to treatment. Tropical Medicine & International Health, 14(5), 1–10.

UNAIDS. (2024). Global AIDS update 2024: The path that ends AIDS. Joint United Nations Programme on HIV/AIDS (UNAIDS).

UNAIDS. (2024). Eastern and Southern Africa HIV regional overview. Joint United Nations Programme on HIV/AIDS (UNAIDS).

World Health Organization (WHO). (2024). HIV drug resistance report 2024. World Health Organization.